Cargando…
Benefits of heart failure-specific pharmacotherapy in frail hospitalised patients: a cross-sectional study
OBJECTIVES: Up to 50% of heart failure (HF) patients may be frail and have worse clinical outcomes than non-frail patients. The benefits of HF-specific pharmacotherapy (beta-blockers, ACE-inhibitors/angiotensin-receptor-blockers and mineralocorticoid-receptor-antagonist) in this population are uncle...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486223/ https://www.ncbi.nlm.nih.gov/pubmed/36123054 http://dx.doi.org/10.1136/bmjopen-2021-059905 |